Business
AbCellera Announces Virtual Presentations at Investor Conferences in November
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following virtual investor conferences:\n\n\nCredit Suisse 30th Annual Virtual Healthcare Conference on Thursday, November 11 at 7:30 a.m. Pacific Time\n\n\nStifel 2021 Virtual Healthcare Conference on Tuesday, November 16 at 10:20 a.m. Pacific Time\n\n\nPiper Sandler 33rd Annual Virtual Healthcare Conference on Tuesday, November 30 (recorded and available on November 22)\n\n\nLive audio webcasts of the Credit Suisse and Stifel presentations may be accessed through links that will be posted on AbCellera’s Investor Relations website. A replay of all three recordings will be available at the same location following the presentations.\n\nAbout AbCellera Biologics Inc.\n\nAbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com\n\nSource: AbCellera Biologics Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211104006242/en/\n\nMedia: Jessica Yingling, Ph.D.; [email protected], +1(236)521-6774\nBusiness Development: Neil Berkley; [email protected], +1(604)559-9005\nInvestor Relations: Melanie Solomon; [email protected], +1(778)729-9116\n\nSource: AbCellera Biologics Inc.","length":3759,"tagName":"div"}]